

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.53560528 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.53560528 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 6.53560528 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 6.53560528 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 6.53560528 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.53560528 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.44757249 |
| 8 | negative regulation of cell killing (GO:0031342) | 6.39700904 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.39700904 |
| 10 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.85278362 |
| 11 | detection of molecule of bacterial origin (GO:0032490) | 5.62818947 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 5.35433982 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.35376237 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 5.33806920 |
| 15 | detection of other organism (GO:0098543) | 5.24944113 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.17747809 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.00432538 |
| 18 | cellular extravasation (GO:0045123) | 4.98523110 |
| 19 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.96372040 |
| 20 | detection of external biotic stimulus (GO:0098581) | 4.95723293 |
| 21 | response to peptidoglycan (GO:0032494) | 4.91744078 |
| 22 | detection of bacterium (GO:0016045) | 4.78280607 |
| 23 | neutrophil activation (GO:0042119) | 4.64948075 |
| 24 | microglial cell activation (GO:0001774) | 4.63184174 |
| 25 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.62599481 |
| 26 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.57811429 |
| 27 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.49402585 |
| 28 | negative regulation of interleukin-12 production (GO:0032695) | 4.48531342 |
| 29 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.41639128 |
| 30 | response to host immune response (GO:0052572) | 4.41639128 |
| 31 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.40330786 |
| 32 | respiratory burst (GO:0045730) | 4.39685415 |
| 33 | response to interleukin-15 (GO:0070672) | 4.36106472 |
| 34 | neutrophil mediated immunity (GO:0002446) | 4.35662148 |
| 35 | detection of biotic stimulus (GO:0009595) | 4.33086626 |
| 36 | regulation of gamma-delta T cell activation (GO:0046643) | 4.24544109 |
| 37 | leukocyte aggregation (GO:0070486) | 4.21450991 |
| 38 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.20721312 |
| 39 | macrophage activation (GO:0042116) | 4.18943757 |
| 40 | granulocyte activation (GO:0036230) | 4.16647784 |
| 41 | cellular response to interleukin-15 (GO:0071350) | 4.06688864 |
| 42 | response to host (GO:0075136) | 4.04375588 |
| 43 | response to host defenses (GO:0052200) | 4.04375588 |
| 44 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.04375588 |
| 45 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.99493964 |
| 46 | myeloid cell activation involved in immune response (GO:0002275) | 3.86621250 |
| 47 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.81622230 |
| 48 | regulation of mast cell degranulation (GO:0043304) | 3.79680933 |
| 49 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.77624856 |
| 50 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.77446962 |
| 51 | negative regulation of T cell mediated immunity (GO:0002710) | 3.73507141 |
| 52 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.68846666 |
| 53 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.64971729 |
| 54 | myeloid leukocyte mediated immunity (GO:0002444) | 3.62647383 |
| 55 | immunoglobulin mediated immune response (GO:0016064) | 3.60325764 |
| 56 | positive regulation of mast cell activation (GO:0033005) | 3.58038335 |
| 57 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.50832249 |
| 58 | B cell receptor signaling pathway (GO:0050853) | 3.44432660 |
| 59 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.43986960 |
| 60 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.40193019 |
| 61 | leukocyte degranulation (GO:0043299) | 3.39570289 |
| 62 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.36967161 |
| 63 | regulation of mast cell activation (GO:0033003) | 3.36880058 |
| 64 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.30977276 |
| 65 | regulation of leukocyte degranulation (GO:0043300) | 3.29873141 |
| 66 | dendritic cell migration (GO:0036336) | 3.28864105 |
| 67 | regulation of B cell differentiation (GO:0045577) | 3.23278207 |
| 68 | negative regulation of phagocytosis (GO:0050765) | 3.22483044 |
| 69 | regulation of tolerance induction (GO:0002643) | 3.20561705 |
| 70 | germinal center formation (GO:0002467) | 3.16904007 |
| 71 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.15335859 |
| 72 | response to muramyl dipeptide (GO:0032495) | 3.14049402 |
| 73 | dendritic cell chemotaxis (GO:0002407) | 3.14018064 |
| 74 | regulation of T cell tolerance induction (GO:0002664) | 3.12593921 |
| 75 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.11136174 |
| 76 | defense response to protozoan (GO:0042832) | 3.09896221 |
| 77 | regulation of regulated secretory pathway (GO:1903305) | 3.09345198 |
| 78 | positive regulation of mast cell degranulation (GO:0043306) | 3.06572422 |
| 79 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.06572422 |
| 80 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.05607342 |
| 81 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.05185067 |
| 82 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.04844977 |
| 83 | type I interferon signaling pathway (GO:0060337) | 3.04037947 |
| 84 | cellular response to type I interferon (GO:0071357) | 3.04037947 |
| 85 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.03359757 |
| 86 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.03359757 |
| 87 | myeloid leukocyte activation (GO:0002274) | 3.03010918 |
| 88 | negative regulation of interleukin-6 production (GO:0032715) | 3.02611405 |
| 89 | response to type I interferon (GO:0034340) | 3.01831405 |
| 90 | neutrophil chemotaxis (GO:0030593) | 2.99620007 |
| 91 | tolerance induction (GO:0002507) | 2.97440770 |
| 92 | negative thymic T cell selection (GO:0045060) | 2.97326030 |
| 93 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.95753558 |
| 94 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.92927884 |
| 95 | neutrophil migration (GO:1990266) | 2.92106395 |
| 96 | negative T cell selection (GO:0043383) | 2.91891820 |
| 97 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.91685686 |
| 98 | positive regulation of B cell differentiation (GO:0045579) | 2.91541333 |
| 99 | negative regulation of type 2 immune response (GO:0002829) | 2.91141885 |
| 100 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.90629333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.18558184 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.93129043 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.42035256 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.08198414 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.90295019 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.74777889 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.43837926 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.37249830 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.01882937 |
| 10 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.94569819 |
| 11 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.86852325 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.85891209 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.83056754 |
| 14 | SPI1_23127762_ChIP-Seq_K562_Human | 2.77317341 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.74034280 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.62918338 |
| 17 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.56927487 |
| 18 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.41778409 |
| 19 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.40609890 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.37230469 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.34972328 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.31930620 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.29647700 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 2.28287553 |
| 25 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.22714428 |
| 26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.20498477 |
| 27 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.18229813 |
| 28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.18019237 |
| 29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.06786328 |
| 30 | UTX_26944678_Chip-Seq_JUKART_Human | 2.04251950 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.03804163 |
| 32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.03672840 |
| 33 | MYB_26560356_Chip-Seq_TH1_Human | 2.03098404 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.00079829 |
| 35 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.93270811 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.87747783 |
| 37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.77800884 |
| 38 | MYC_22102868_ChIP-Seq_BL_Human | 1.77546490 |
| 39 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.76627970 |
| 40 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75481697 |
| 41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.74318435 |
| 42 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.74094708 |
| 43 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.69413757 |
| 44 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.64433869 |
| 45 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.62496971 |
| 46 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.61968420 |
| 47 | MAF_26560356_Chip-Seq_TH2_Human | 1.59465876 |
| 48 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.57854539 |
| 49 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.54796013 |
| 50 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.52522645 |
| 51 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.50657269 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46873894 |
| 53 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.42061560 |
| 54 | GATA3_26560356_Chip-Seq_TH2_Human | 1.41860639 |
| 55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40659463 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39624022 |
| 57 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39374733 |
| 58 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.36677966 |
| 59 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35113487 |
| 60 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34199185 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34131866 |
| 62 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.33574130 |
| 63 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31377613 |
| 64 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30321555 |
| 65 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30318992 |
| 66 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.25105468 |
| 67 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.25097633 |
| 68 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.24876225 |
| 69 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21728544 |
| 70 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21150535 |
| 71 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20663664 |
| 72 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20329969 |
| 73 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17102487 |
| 74 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16557531 |
| 75 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14966269 |
| 76 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11859310 |
| 77 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.09874896 |
| 78 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.09743034 |
| 79 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09539936 |
| 80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09194373 |
| 81 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.05398797 |
| 82 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.04132362 |
| 83 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.03466290 |
| 84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02942626 |
| 85 | GATA2_19941826_ChIP-Seq_K562_Human | 1.02582233 |
| 86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99071223 |
| 87 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.98548907 |
| 88 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98016883 |
| 89 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91839344 |
| 90 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.87077177 |
| 91 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.86061827 |
| 92 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.85616649 |
| 93 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85544120 |
| 94 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.80268029 |
| 95 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.79223208 |
| 96 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.78859404 |
| 97 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.78048129 |
| 98 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77834291 |
| 99 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.75700880 |
| 100 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.72701602 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 5.63305402 |
| 2 | MP0003436_decreased_susceptibility_to | 4.32193486 |
| 3 | MP0003303_peritoneal_inflammation | 4.00227559 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.62708887 |
| 5 | MP0002419_abnormal_innate_immunity | 3.23825314 |
| 6 | MP0005025_abnormal_response_to | 2.85326933 |
| 7 | MP0001800_abnormal_humoral_immune | 2.84305562 |
| 8 | MP0005671_abnormal_response_to | 2.79552814 |
| 9 | MP0009785_altered_susceptibility_to | 2.78704376 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.72606647 |
| 11 | MP0000685_abnormal_immune_system | 2.68878821 |
| 12 | MP0001790_abnormal_immune_system | 2.60117028 |
| 13 | MP0005387_immune_system_phenotype | 2.60117028 |
| 14 | MP0008260_abnormal_autophagy | 2.54747356 |
| 15 | MP0002723_abnormal_immune_serum | 2.54261527 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.52413973 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.49188579 |
| 18 | MP0006082_CNS_inflammation | 2.47467828 |
| 19 | MP0001819_abnormal_immune_cell | 2.46555546 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.43898405 |
| 21 | MP0003300_gastrointestinal_ulcer | 2.34767513 |
| 22 | MP0001533_abnormal_skeleton_physiology | 2.19979637 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.19671283 |
| 24 | MP0002132_abnormal_respiratory_system | 2.10494649 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.04715282 |
| 26 | MP0002405_respiratory_system_inflammati | 2.02199667 |
| 27 | MP0003828_pulmonary_edema | 1.96128635 |
| 28 | MP0003763_abnormal_thymus_physiology | 1.94454256 |
| 29 | MP0002277_abnormal_respiratory_mucosa | 1.91544385 |
| 30 | MP0004381_abnormal_hair_follicle | 1.87715999 |
| 31 | MP0002398_abnormal_bone_marrow | 1.87383314 |
| 32 | MP0000716_abnormal_immune_system | 1.84018647 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.80655355 |
| 34 | MP0005451_abnormal_body_composition | 1.78772667 |
| 35 | MP0009278_abnormal_bone_marrow | 1.72229205 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.71794079 |
| 37 | MP0004883_abnormal_blood_vessel | 1.71089326 |
| 38 | MP0003866_abnormal_defecation | 1.66146887 |
| 39 | MP0009764_decreased_sensitivity_to | 1.63556427 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.62931622 |
| 41 | MP0004947_skin_inflammation | 1.59572921 |
| 42 | MP0003183_abnormal_peptide_metabolism | 1.58926205 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.57018501 |
| 44 | MP0002722_abnormal_immune_system | 1.55108435 |
| 45 | MP0002396_abnormal_hematopoietic_system | 1.54910149 |
| 46 | MP0000689_abnormal_spleen_morphology | 1.53125970 |
| 47 | MP0002429_abnormal_blood_cell | 1.44738541 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 1.40718028 |
| 49 | MP0008469_abnormal_protein_level | 1.38351323 |
| 50 | MP0000858_altered_metastatic_potential | 1.37917423 |
| 51 | MP0000703_abnormal_thymus_morphology | 1.37863955 |
| 52 | MP0005164_abnormal_response_to | 1.34414289 |
| 53 | MP0005310_abnormal_salivary_gland | 1.27724955 |
| 54 | MP0003075_altered_response_to | 1.27646454 |
| 55 | MP0003690_abnormal_glial_cell | 1.24136269 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.23347255 |
| 57 | MP0001545_abnormal_hematopoietic_system | 1.23347255 |
| 58 | MP0001851_eye_inflammation | 1.21442318 |
| 59 | MP0000569_abnormal_digit_pigmentation | 1.20249599 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.12673462 |
| 61 | MP0004510_myositis | 1.10525589 |
| 62 | MP0002166_altered_tumor_susceptibility | 1.07909941 |
| 63 | MP0005166_decreased_susceptibility_to | 0.98298503 |
| 64 | MP0005075_abnormal_melanosome_morpholog | 0.95555772 |
| 65 | MP0003448_altered_tumor_morphology | 0.94633388 |
| 66 | MP0003656_abnormal_erythrocyte_physiolo | 0.92835725 |
| 67 | MP0000015_abnormal_ear_pigmentation | 0.89635973 |
| 68 | MP0003221_abnormal_cardiomyocyte_apopto | 0.86238467 |
| 69 | MP0005390_skeleton_phenotype | 0.84349746 |
| 70 | MP0008004_abnormal_stomach_pH | 0.83147697 |
| 71 | MP0003045_fibrosis | 0.83046152 |
| 72 | MP0000604_amyloidosis | 0.81935733 |
| 73 | MP0001663_abnormal_digestive_system | 0.81361448 |
| 74 | MP0009763_increased_sensitivity_to | 0.80825264 |
| 75 | MP0000343_altered_response_to | 0.80748823 |
| 76 | MP0002928_abnormal_bile_duct | 0.79218287 |
| 77 | MP0004130_abnormal_muscle_cell | 0.75714867 |
| 78 | MP0003252_abnormal_bile_duct | 0.73495622 |
| 79 | MP0004808_abnormal_hematopoietic_stem | 0.70064403 |
| 80 | MP0002332_abnormal_exercise_endurance | 0.68443171 |
| 81 | MP0009765_abnormal_xenobiotic_induced | 0.67344516 |
| 82 | MP0000490_abnormal_crypts_of | 0.66394821 |
| 83 | MP0000249_abnormal_blood_vessel | 0.65985855 |
| 84 | MP0001853_heart_inflammation | 0.65883200 |
| 85 | MP0002006_tumorigenesis | 0.65429155 |
| 86 | MP0008874_decreased_physiological_sensi | 0.63906375 |
| 87 | MP0004484_altered_response_of | 0.63109161 |
| 88 | MP0005084_abnormal_gallbladder_morpholo | 0.62660737 |
| 89 | MP0001986_abnormal_taste_sensitivity | 0.61731146 |
| 90 | MP0002133_abnormal_respiratory_system | 0.61700200 |
| 91 | MP0005388_respiratory_system_phenotype | 0.61700200 |
| 92 | MP0005377_hearing/vestibular/ear_phenot | 0.60855609 |
| 93 | MP0003878_abnormal_ear_physiology | 0.60855609 |
| 94 | MP0005058_abnormal_lysosome_morphology | 0.58925832 |
| 95 | MP0003795_abnormal_bone_structure | 0.58485197 |
| 96 | MP0000371_diluted_coat_color | 0.55634368 |
| 97 | MP0001958_emphysema | 0.54633282 |
| 98 | MP0005376_homeostasis/metabolism_phenot | 0.53252621 |
| 99 | MP0005248_abnormal_Harderian_gland | 0.52258168 |
| 100 | MP0004858_abnormal_nervous_system | 0.51585004 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.99794444 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.30586122 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.28636977 |
| 4 | Myositis (HP:0100614) | 6.23263050 |
| 5 | Orchitis (HP:0100796) | 6.12882699 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 5.79910798 |
| 7 | Optic neuritis (HP:0100653) | 5.79910798 |
| 8 | Abnormality of macrophages (HP:0004311) | 5.33346841 |
| 9 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.26219939 |
| 10 | Stomatitis (HP:0010280) | 5.04877968 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.80683562 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 4.50365722 |
| 13 | Keratoconjunctivitis sicca (HP:0001097) | 4.28604751 |
| 14 | Recurrent fungal infections (HP:0002841) | 4.25473144 |
| 15 | Chronic obstructive pulmonary disease (HP:0006510) | 4.19447903 |
| 16 | Obstructive lung disease (HP:0006536) | 4.19447903 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.16775971 |
| 18 | Hypochromic microcytic anemia (HP:0004840) | 4.13914282 |
| 19 | Recurrent skin infections (HP:0001581) | 4.05336906 |
| 20 | Mediastinal lymphadenopathy (HP:0100721) | 4.03489046 |
| 21 | Meningitis (HP:0001287) | 4.02527478 |
| 22 | Keratoconjunctivitis (HP:0001096) | 3.96265034 |
| 23 | Spontaneous hematomas (HP:0007420) | 3.93280110 |
| 24 | Gingivitis (HP:0000230) | 3.87737797 |
| 25 | Encephalitis (HP:0002383) | 3.85379767 |
| 26 | Urticaria (HP:0001025) | 3.64560911 |
| 27 | Chest pain (HP:0100749) | 3.51070384 |
| 28 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.50850119 |
| 29 | Recurrent cutaneous fungal infections (HP:0011370) | 3.50850119 |
| 30 | Peritonitis (HP:0002586) | 3.49697471 |
| 31 | Vasculitis (HP:0002633) | 3.49027744 |
| 32 | Increased IgE level (HP:0003212) | 3.43846049 |
| 33 | T lymphocytopenia (HP:0005403) | 3.41842696 |
| 34 | Hypochromic anemia (HP:0001931) | 3.36258964 |
| 35 | Abnormality of T cell number (HP:0011839) | 3.26320228 |
| 36 | Hemoptysis (HP:0002105) | 3.26120254 |
| 37 | Gingival bleeding (HP:0000225) | 3.24716573 |
| 38 | Prolonged bleeding time (HP:0003010) | 3.22335851 |
| 39 | Pulmonary infiltrates (HP:0002113) | 3.21154031 |
| 40 | Episodic fever (HP:0001954) | 3.18590097 |
| 41 | Arterial thrombosis (HP:0004420) | 3.12514401 |
| 42 | Cellulitis (HP:0100658) | 3.09034114 |
| 43 | Anorexia (HP:0002039) | 2.94769665 |
| 44 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.93632618 |
| 45 | Leukocytosis (HP:0001974) | 2.89893103 |
| 46 | Pulmonary embolism (HP:0002204) | 2.85180666 |
| 47 | Abnormality of T cells (HP:0002843) | 2.75222723 |
| 48 | Amyloidosis (HP:0011034) | 2.72843371 |
| 49 | Epistaxis (HP:0000421) | 2.72343407 |
| 50 | Microcytic anemia (HP:0001935) | 2.62530382 |
| 51 | Gangrene (HP:0100758) | 2.60153049 |
| 52 | Inflammation of the large intestine (HP:0002037) | 2.53921941 |
| 53 | Abnormality of the pleura (HP:0002103) | 2.48837375 |
| 54 | Osteomyelitis (HP:0002754) | 2.46295399 |
| 55 | Abnormality of the peritoneum (HP:0002585) | 2.42507002 |
| 56 | Gastrointestinal inflammation (HP:0004386) | 2.42122262 |
| 57 | Sepsis (HP:0100806) | 2.42106536 |
| 58 | Recurrent viral infections (HP:0004429) | 2.42105659 |
| 59 | Increased IgM level (HP:0003496) | 2.38559571 |
| 60 | Granulocytopenia (HP:0001913) | 2.38141756 |
| 61 | Pustule (HP:0200039) | 2.33183065 |
| 62 | Slow saccadic eye movements (HP:0000514) | 2.28566767 |
| 63 | Abnormality of the endocardium (HP:0004306) | 2.27377649 |
| 64 | Petechiae (HP:0000967) | 2.25608201 |
| 65 | Abnormality of T cell physiology (HP:0011840) | 2.23063987 |
| 66 | Subacute progressive viral hepatitis (HP:0006572) | 2.20530256 |
| 67 | Glomerulopathy (HP:0100820) | 2.20486170 |
| 68 | Keratitis (HP:0000491) | 2.13305819 |
| 69 | Vertigo (HP:0002321) | 2.11215862 |
| 70 | Eosinophilia (HP:0001880) | 2.09567344 |
| 71 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.09082822 |
| 72 | Acne (HP:0001061) | 2.09081452 |
| 73 | Abnormality of the pericardium (HP:0001697) | 2.08858819 |
| 74 | Lymphopenia (HP:0001888) | 2.08731367 |
| 75 | Abnormal platelet volume (HP:0011876) | 2.07990776 |
| 76 | Hypergammaglobulinemia (HP:0010702) | 2.05436687 |
| 77 | Panhypogammaglobulinemia (HP:0003139) | 2.05202393 |
| 78 | Skin ulcer (HP:0200042) | 1.99559423 |
| 79 | Alveolar cell carcinoma (HP:0006519) | 1.99422615 |
| 80 | Acute hepatic failure (HP:0006554) | 1.97959280 |
| 81 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.96913125 |
| 82 | Viral hepatitis (HP:0006562) | 1.94623090 |
| 83 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.92840311 |
| 84 | Premature loss of primary teeth (HP:0006323) | 1.89889012 |
| 85 | Cheilitis (HP:0100825) | 1.84378938 |
| 86 | Recurrent pneumonia (HP:0006532) | 1.84247492 |
| 87 | Toxemia of pregnancy (HP:0100603) | 1.83528198 |
| 88 | Purpura (HP:0000979) | 1.82500151 |
| 89 | Polycythemia (HP:0001901) | 1.81675342 |
| 90 | Polyneuropathy (HP:0001271) | 1.81453567 |
| 91 | Increased serum ferritin (HP:0003281) | 1.81310039 |
| 92 | Thrombophlebitis (HP:0004418) | 1.80663158 |
| 93 | Difficulty running (HP:0009046) | 1.79477566 |
| 94 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.78877634 |
| 95 | Recurrent bronchitis (HP:0002837) | 1.78807604 |
| 96 | Hepatosplenomegaly (HP:0001433) | 1.78151946 |
| 97 | Abnormality of eosinophils (HP:0001879) | 1.77564735 |
| 98 | Abnormality of iron homeostasis (HP:0011031) | 1.77393556 |
| 99 | Skin rash (HP:0000988) | 1.75639689 |
| 100 | Hypermelanotic macule (HP:0001034) | 1.75346205 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.01650913 |
| 2 | IRAK4 | 3.55530414 |
| 3 | BLK | 3.48028715 |
| 4 | MAP4K1 | 3.14109909 |
| 5 | MAP2K3 | 3.07990833 |
| 6 | CSK | 2.96649037 |
| 7 | TYK2 | 2.64316943 |
| 8 | ERN1 | 2.58630947 |
| 9 | FES | 2.41404067 |
| 10 | EPHB1 | 2.40806929 |
| 11 | GRK6 | 2.40605713 |
| 12 | TNK2 | 2.10023354 |
| 13 | ZAP70 | 2.02174528 |
| 14 | TAOK1 | 1.91106514 |
| 15 | FGR | 1.87720129 |
| 16 | TXK | 1.86377137 |
| 17 | MAP3K3 | 1.86276008 |
| 18 | JAK3 | 1.83679781 |
| 19 | HCK | 1.77924729 |
| 20 | BTK | 1.72235065 |
| 21 | PRPF4B | 1.67563853 |
| 22 | KSR2 | 1.61646689 |
| 23 | SYK | 1.60234797 |
| 24 | MAP3K14 | 1.57756592 |
| 25 | JAK2 | 1.54410087 |
| 26 | MAP3K11 | 1.51843038 |
| 27 | YES1 | 1.51716888 |
| 28 | TAOK3 | 1.49479015 |
| 29 | IKBKE | 1.47283620 |
| 30 | MAP3K1 | 1.42635997 |
| 31 | IRAK1 | 1.38024995 |
| 32 | LYN | 1.36139625 |
| 33 | IRAK2 | 1.25873858 |
| 34 | MAP3K2 | 1.24304344 |
| 35 | JAK1 | 1.20411164 |
| 36 | SIK3 | 1.18135937 |
| 37 | MATK | 1.17729140 |
| 38 | MAP3K13 | 1.08333169 |
| 39 | TBK1 | 1.07354575 |
| 40 | LCK | 1.06406062 |
| 41 | ITK | 1.05498816 |
| 42 | PTK6 | 1.01778466 |
| 43 | MARK3 | 0.99033689 |
| 44 | MARK2 | 0.98983217 |
| 45 | CSF1R | 0.95779375 |
| 46 | CDK19 | 0.93456564 |
| 47 | BMPR2 | 0.89689404 |
| 48 | MAP3K5 | 0.86409638 |
| 49 | MAP3K6 | 0.85412097 |
| 50 | KIT | 0.84377631 |
| 51 | PDK1 | 0.84151224 |
| 52 | MAP2K4 | 0.84058016 |
| 53 | TEC | 0.83659932 |
| 54 | LRRK2 | 0.82418657 |
| 55 | PIK3CG | 0.82266907 |
| 56 | PTK2B | 0.81970183 |
| 57 | STK10 | 0.81158814 |
| 58 | PRKD2 | 0.77709816 |
| 59 | TAOK2 | 0.76345669 |
| 60 | PDPK1 | 0.73372294 |
| 61 | SGK3 | 0.72262522 |
| 62 | IKBKB | 0.71193443 |
| 63 | TGFBR2 | 0.70120502 |
| 64 | RAF1 | 0.69524205 |
| 65 | FYN | 0.68812605 |
| 66 | STK11 | 0.68168068 |
| 67 | FGFR3 | 0.65965654 |
| 68 | EPHA3 | 0.65962962 |
| 69 | KSR1 | 0.65107463 |
| 70 | SIK2 | 0.64699483 |
| 71 | WNK1 | 0.62996716 |
| 72 | DYRK1B | 0.62269581 |
| 73 | STK38 | 0.60339284 |
| 74 | MAP3K7 | 0.57050744 |
| 75 | SGK2 | 0.56946314 |
| 76 | TESK2 | 0.56727581 |
| 77 | NLK | 0.54533868 |
| 78 | DAPK2 | 0.52824443 |
| 79 | MAPK12 | 0.52382184 |
| 80 | TRIB3 | 0.52283435 |
| 81 | RET | 0.48000956 |
| 82 | PRKCQ | 0.47016237 |
| 83 | PIM1 | 0.46693150 |
| 84 | FGFR4 | 0.46344292 |
| 85 | SMG1 | 0.45604478 |
| 86 | RPS6KL1 | 0.44138281 |
| 87 | RPS6KC1 | 0.44138281 |
| 88 | DYRK3 | 0.43936266 |
| 89 | MAPK7 | 0.43124638 |
| 90 | HIPK2 | 0.41744245 |
| 91 | MAP2K6 | 0.41527592 |
| 92 | PRKCZ | 0.41155809 |
| 93 | RPS6KA6 | 0.39831918 |
| 94 | STK24 | 0.38973392 |
| 95 | MAPKAPK2 | 0.38956724 |
| 96 | CDC42BPA | 0.36605418 |
| 97 | PRKG2 | 0.36065658 |
| 98 | CAMK4 | 0.34112322 |
| 99 | CAMKK1 | 0.33412541 |
| 100 | GRK7 | 0.28774664 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.08980577 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 3.08499574 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.82979564 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.43405887 |
| 5 | Tuberculosis_Homo sapiens_hsa05152 | 2.28008498 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.27572941 |
| 7 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.27318110 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.11631457 |
| 9 | Malaria_Homo sapiens_hsa05144 | 2.04291176 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.03010389 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.00606745 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.91706368 |
| 13 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.82245923 |
| 14 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.82195431 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.79407785 |
| 16 | Measles_Homo sapiens_hsa05162 | 1.77839326 |
| 17 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.70948093 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.70900710 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.67139079 |
| 20 | Legionellosis_Homo sapiens_hsa05134 | 1.66181509 |
| 21 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.62746556 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.56729831 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.53972116 |
| 24 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50802132 |
| 25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.43655281 |
| 26 | Phagosome_Homo sapiens_hsa04145 | 1.43090961 |
| 27 | Influenza A_Homo sapiens_hsa05164 | 1.42705916 |
| 28 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.42136107 |
| 29 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.41593374 |
| 30 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.40292428 |
| 31 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.36522508 |
| 32 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.32935399 |
| 33 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.32023309 |
| 34 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.30703568 |
| 35 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28948381 |
| 36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.26574527 |
| 37 | Viral myocarditis_Homo sapiens_hsa05416 | 1.25913189 |
| 38 | Platelet activation_Homo sapiens_hsa04611 | 1.20697503 |
| 39 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.19734017 |
| 40 | Hepatitis B_Homo sapiens_hsa05161 | 1.19183798 |
| 41 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.12295724 |
| 42 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.09802690 |
| 43 | Hepatitis C_Homo sapiens_hsa05160 | 1.08336406 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.05975754 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.01593013 |
| 46 | Salmonella infection_Homo sapiens_hsa05132 | 1.01517994 |
| 47 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98553026 |
| 48 | Pertussis_Homo sapiens_hsa05133 | 0.97669647 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 0.97053639 |
| 50 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.97028486 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 0.94093080 |
| 52 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.91229088 |
| 53 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90730384 |
| 54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.89230654 |
| 55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.88653629 |
| 56 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.86373965 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.85933215 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83870337 |
| 59 | Endocytosis_Homo sapiens_hsa04144 | 0.82532367 |
| 60 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.82527040 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80849640 |
| 62 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78786072 |
| 63 | Endometrial cancer_Homo sapiens_hsa05213 | 0.78185376 |
| 64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76737276 |
| 65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.75734814 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.75201873 |
| 67 | Asthma_Homo sapiens_hsa05310 | 0.73357207 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72159896 |
| 69 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.69703971 |
| 70 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68575115 |
| 71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67946667 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67750186 |
| 73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67631774 |
| 74 | Amoebiasis_Homo sapiens_hsa05146 | 0.66039557 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.65694995 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65183369 |
| 77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.64232360 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.63447753 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62154281 |
| 80 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.61890001 |
| 81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61861676 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61676268 |
| 83 | Lysosome_Homo sapiens_hsa04142 | 0.60598677 |
| 84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59864150 |
| 85 | Colorectal cancer_Homo sapiens_hsa05210 | 0.57568829 |
| 86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.56475621 |
| 87 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54788636 |
| 88 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53506897 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52050814 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.52050583 |
| 91 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.51753939 |
| 92 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50502168 |
| 93 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50190824 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46631076 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46305008 |
| 96 | Prostate cancer_Homo sapiens_hsa05215 | 0.45363732 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.40937123 |
| 98 | Glioma_Homo sapiens_hsa05214 | 0.40893617 |
| 99 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.39805709 |
| 100 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39112591 |

